BHVN

Biohaven
BHVN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.58B
EV
$1.29B
Shares Outstanding
102.11M
Beta
3.64

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$55.08
P/E 2025E
-
P/Revenue 2025E
247.70x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biohaven Ltd.

gainify
BHVN

Biohaven Ltd.

BHVN

Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company’s pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treat...

Sector

Healthcare

Industry

Biotechnology

CEO

Coric, Vladimir

Employees

256

IPO Date

2022-09-23

Headquarters

215 Church Street, New Haven, Connecticut, 06510, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.